Recent Finacing
Recent Raise
NiKang Therapeutics is a clinical-stage biotech developing small-molecule oncology drugs using structure-based drug design and target structural biology, with a pipeline including a HIF‑2α inhibitor and CBC Group incubation.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
